Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
184,457
clinical trials

Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hematology Oncology Consultants-Clarkston
mi
from
Clarkston, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Memorial Sloan Kettering Commack
mi
from
Commack, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Ochsner Hematology Oncology North Shore - Covington (West Region)
mi
from
Covington, LA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Deer River Clinic
mi
from
Deer River, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northwestern Medicine Cancer Center Kishwaukee
mi
from
DeKalb, IL
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Mercy Cancer Center - Elk Grove
mi
from
Elk Grove, CA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
University of Florida Health Science Center ?? Gainesville
mi
from
Gainesville, FL
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Northeast Georgia Medical Center-Gainesville
mi
from
Gainesville, GA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Crozer Regional Cancer Center at Brinton Lake
mi
from
Glen Mills, PA
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Yale-New Haven Shoreline Medical Center
mi
from
Guilford, CT
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health Hibbing Clinic
mi
from
Hibbing, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Hawaii Oncology Inc-POB I
mi
from
Honolulu, HI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Essentia Health - Jamestown Clinic
mi
from
Jamestown, ND
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Good Samaritan Medical Center
mi
from
Lafayette, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Michigan Breast Specialists-Macomb Township
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Macomb Medical Campus
mi
from
Macomb, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Fairview Maple Grove Medical Center
mi
from
Maple Grove, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UP Health System Hematology Oncology Marquette
mi
from
Marquette, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
UH Seidman Cancer Center at Southwest General Hospital
mi
from
Middleburg Heights, OH
Click here to add this to my saved trials
Oncology Clinical Trial
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial)
Status: Enrolling, Phase III
Updated: 12/31/1969
Lake Norman Radiation Oncology Center-Mooresville
mi
from
Mooresville, NC
Click here to add this to my saved trials
BIPOLAR DISORDER Clinical Trial
Efficacy and Safety Trial of Flexible Doses of Oral Ziprasidone in Children and Adolescents With Bipolar I Disorder
Status: Enrolling, Phase III
Updated: 12/31/1969
Core Clinical Research
mi
from
Everett, WA
Click here to add this to my saved trials
Relapsing Forms of Multiple Sclerosis Clinical Trial
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling, Phase II
Updated: 12/3/2015
Clinical Research Facility
mi
from
Indianapolis, IN
Click here to add this to my saved trials
Relapsing Forms of Multiple Sclerosis Clinical Trial
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling, Phase II
Updated: 12/3/2015
Clinical Research Facility
mi
from
New York, NY
Click here to add this to my saved trials
Relapsing Forms of Multiple Sclerosis Clinical Trial
Vaccination Response in Tecfidera-Treated Versus Interferon-Treated Participants With Relapsing Forms of Multiple Sclerosis.
Status: Enrolling, Phase II
Updated: 12/3/2015
Clinical Research Facility
mi
from
Round Rock, TX
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Atlanta, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Fargo, ND
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Hialeah, FL
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Oxon Hill, MD
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Roswell, GA
Click here to add this to my saved trials
Type 2 Diabetes Mellitus Clinical Trial
Ertugliflozin and Sitagliptin Co-administration Factorial Study (MK-8835-005)
Status: Enrolling, Phase III
Updated: 3/11/2015
Clinical Research Facility
mi
from
Upland, CA
Click here to add this to my saved trials
Moderate-severe Pain Clinical Trial
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling, Phase IV
Updated: 12/31/1969
University of Illinois at the Med Center, University of Illinois
mi
from
Chicago, IL
Click here to add this to my saved trials
Moderate-severe Pain Clinical Trial
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling, Phase IV
Updated: 12/31/1969
East Carolina University Brody School of Medicine(ECU)
mi
from
Greenville, NC
Click here to add this to my saved trials
Moderate-severe Pain Clinical Trial
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling, Phase IV
Updated: 12/31/1969
Jackson Memorial Hospital - Pharmacy Department Basement West
mi
from
Miami, FL
Click here to add this to my saved trials
Moderate-severe Pain Clinical Trial
Safety and Pharmacokinetic Study of EMBEDA in Children Ages 7-17 With Pain
Status: Enrolling, Phase IV
Updated: 12/31/1969
UCI Medical Center-Outpatient Pharmacy
mi
from
Orange, CA
Click here to add this to my saved trials
Chronic Hepatitis C Clinical Trial
Study of Efficacy and Safety of Grazoprevir (MK-5172) + Elbasvir (MK-8742) in Chronic Hepatitis C Participants With Child-Pugh (CP)-B Hepatic Insufficiency (MK-5172-059)
Status: Enrolling, Phase II, III
Updated: 3/30/2015
Clinical Research Facility
mi
from
San Antonio, TX
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Buffalo, NY
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Miami, FL
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Sacramento, CA
Click here to add this to my saved trials
HIV Infection Clinical Trial
Evaluation of the Safety and Efficacy of Reformulated Raltegravir (MK-0518) 1200 mg Once Daily in Combination With TRUVADA™ in Human Immunodeficiency Virus (HIV)-1 Infected, Treatment-Naive Participants (MK-0518-292)
Status: Enrolling, Phase III
Updated: 11/5/2014
Clinical Research Facility
mi
from
Santa Fe, NM
Click here to add this to my saved trials
Oncology Clinical Trial
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
Status: Enrolling
Updated: 12/31/1969
Memoral Sloan Kettering Basking Ridge (Consent and follow-up only)
mi
from
Basking Ridge, NJ
Click here to add this to my saved trials
Oncology Clinical Trial
Electronic Skin Surface Brachytherapy for Cutaneous Basal Cell and Squamous Cell Carcinoma
Status: Enrolling
Updated: 12/31/1969
Memorial Sloan Kettering Rockville Centre (Consent and follow-up only)
mi
from
Rockville Centre, NY
Click here to add this to my saved trials
Solid Tumor Clinical Trial
Study of MK-4166 and MK-4166 in Combination With Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-4166-001)
Status: Enrolling, Phase I
Updated: 12/31/1969
Merck Sharp & Dohme
mi
from
North Ryde,
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Marshfield Medical Center
mi
from
Marshfield, WI
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Stanford Cancer Institute Palo Alto
mi
from
Palo Alto, CA
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Delbert Day Cancer Institute at PCRMC
mi
from
Rolla, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Siteman Cancer Center at Saint Peters Hospital
mi
from
Saint Peters, MO
Click here to add this to my saved trials
Immunology / Infectious Diseases, Oncology Clinical Trial
Individualized Treatment in Treating Patients With Stage II-IVB Nasopharyngeal Cancer Based on EBV DNA
Status: Enrolling, Phase II, III
Updated: 12/31/1969
Promedica Flower Hospital
mi
from
Sylvania, OH
Click here to add this to my saved trials
Dermatology / Plastic Surgery, Immunology / Infectious Diseases, Oncology, Reproductive Clinical Trial
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions
Status: Enrolling, Phase III
Updated: 12/31/1969
CrescentCare Health
mi
from
New Orleans, LA
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Baltimore, MD
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Iowa City, IA
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Kansas City, MO
Click here to add this to my saved trials
Cytomegalovirus Infections Clinical Trial
MK-8228 (Letermovir) Versus Placebo in the Prevention of Clinically-Significant Cytomegalovirus (CMV) Infection in Adult, CMV-Seropositive Allogeneic Hematopoietic Stem Cell Transplant Recipients (MK-8228-001)
Status: Enrolling, Phase III
Updated: 3/2/2016
Clinical Research Facility
mi
from
Stanford, CA
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Boise, ID
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Turoctocog Alfa Pegol (N8-GP) in Previously Untreated Patients With Haemophilia A
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Oncology, Psychiatry / Psychology Clinical Trial
Ask Suicide-Screening Questions to Everyone in Medical Settings (asQ em): Development of a Suicide Risk Screening Instrument for Adult Medical Inpatients
Status: Enrolling, Phase
Updated: 12/31/1969
John Peter Smith
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Sickle Cell Disease Clinical Trial
A Study Evaluating the Safety and Efficacy of the LentiGlobin BB305 Drug Product in Severe Sickle Cell Disease
Status: Enrolling, Phase I, II
Updated: 12/31/1969
Clinical Research Facility
mi
from
Chicago, IL
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Boise, ID
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology Clinical Trial
Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B
Status: Enrolling, Phase III
Updated: 12/31/1969
Novo Nordisk Investigational Site
mi
from
Dayton, OH
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
McFarland Clinic PC - Ames
mi
from
Ames, IA
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Central Care Cancer Center - Bolivar
mi
from
Bolivar, MO
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Vincent Hospital Cancer Center Green Bay
mi
from
Green Bay, WI
Click here to add this to my saved trials
Oncology, Other Clinical Trial
Blinatumomab and Combination Chemotherapy or Dasatinib, Prednisone, and Blinatumomab in Treating Older Patients With Acute Lymphoblastic Leukemia
Status: Enrolling, Phase II
Updated: 12/31/1969
Vidant Oncology-Richlands
mi
from
Richlands, NC
Click here to add this to my saved trials
Advanced Non Small Cell Lung Cancer Clinical Trial
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Boston, MA
Click here to add this to my saved trials
Advanced Non Small Cell Lung Cancer Clinical Trial
AZD9291 in Combination With Ascending Doses of Novel Therapeutics
Status: Enrolling, Phase I
Updated: 12/31/1969
Clinical Research Facility
mi
from
Houston, TX
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Dean and St. Mary's Outpatient Center; Medical Research
mi
from
Madison, WI
Click here to add this to my saved trials
Ulcerative Colitis Clinical Trial
A Study Comparing the Efficacy and Safety of Etrolizumab With Adalimumab and Placebo in Participants With Moderate to Severe Ulcerative Colitis (UC) in Participants Naive to Tumor Necrosis Factor (TNF) Inhibitors (Study #2)
Status: Enrolling, Phase III
Updated: 12/31/1969
Westside Internal Medicine
mi
from
New York, NY
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
Norton Children's Hospital
mi
from
Louisville, KY
Click here to add this to my saved trials
Oncology Clinical Trial
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
Status: Enrolling, Phase III
Updated: 12/31/1969
USA Health Strada Patient Care Center
mi
from
Mobile, AL
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
AIS Cancer Center at San Joaquin Community Hospital
mi
from
Bakersfield, CA
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Great Lakes Cancer Management Specialists-Doctors Park
mi
from
East China Township, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Grand Valley Oncology
mi
from
Grand Junction, CO
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Ann M Wierman MD LTD
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Saint Alphonsus Medical Center-Nampa
mi
from
Nampa, ID
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Mercy Health Perrysburg Cancer Center
mi
from
Perrysburg, OH
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
21st Century Oncology-Pontiac
mi
from
Pontiac, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Hope Cancer Center
mi
from
Pontiac, MI
Click here to add this to my saved trials
Bladder Cancer Clinical Trial
S1314, Co-expression Extrapolation (COXEN) Program to Predict Chemotherapy Response in Patients With Bladder Cancer
Status: Enrolling, Phase II
Updated: 12/31/1969
Huron Gastroenterology PC
mi
from
Ypsilanti, MI
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Sanford Joe Lueken Cancer Center
mi
from
Bemidji, MN
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
UCHealth Memorial Hospital Central
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Oncology Clinical Trial
Dose-Escalated Photon IMRT or Proton Beam Radiation Therapy Versus Standard-Dose Radiation Therapy and Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma
Status: Enrolling, Phase II
Updated: 12/31/1969
Texas Oncology - Fort Worth Cancer Center
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Cardiology / Vascular Diseases Clinical Trial
Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location
Status: Enrolling, Phase III
Updated: 12/31/1969
Carolinas Medical Center - Women's Institute
mi
from
Charlotte, NC
Click here to add this to my saved trials
Hematology, Oncology Clinical Trial
Safety Study of MGD006 in Relapsed/Refractory Acute Myeloid Leukemia (AML) or Intermediate-2/High Risk MDS
Status: Enrolling, Phase I
Updated: 9/12/2017
Institut Paoli-Calmettes
mi
from
Marseille,
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Brooklyn, NY
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Kirkland, WA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Orem, UT
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Pasadena, CA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Patchogue, NY
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesias
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Summit, NJ
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
Neurology Clinical Trial
Efficacy and Safety of Amantadine HCl Extended Release Tablets to Treat Parkinson's Disease Patients With Levodopa Induced Dyskinesia.
Status: Enrolling, Phase III
Updated: 2/9/2016
Clinical Research Facility
mi
from
Boulder, CO
Click here to add this to my saved trials